Elena V. Babenko
Saint Petersburg, SPE, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Complex Genomic Alterations in TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia Involving EPOR/JAK2 Amplification, ERG Copy Gains, and TCF3 Deletion.
Journal: Genes, chromosomes & cancer
Published: May 26, 2026
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Bendamustine in Patients with Refractory Acute Leukemia: A Dose-Ranging Study.
Journal: Transplantation and cellular therapy
Published: December 25, 2020
A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure.
Journal: HemaSphere
Published: March 11, 2020
Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma.
Journal: Annals of hematology
Published: March 01, 2020
High prevalence of CD3, NK, and NKT cells in the graft predicts adverse outcome after matched-related and unrelated transplantations with post transplantation cyclophosphamide.
Journal: Bone marrow transplantation
Published: April 14, 2019
Risk-adapted GVHD prophylaxis with post-transplantation cyclophosphamide in adults after related, unrelated, and haploidentical transplantations.
Journal: European journal of haematology
Published: January 17, 2018
Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: January 19, 2016
An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohort.
Journal: Hematology (Amsterdam, Netherlands)
Published: March 27, 2014
Last Updated: 09/26/2026